Innova Capital Partners United States
Innova Capital Partners LLC describes a growth-oriented investment and operating platform spanning venture capital, growth equity, private credit, and real assets. Its stated themes include energy, artificial intelligence, digital infrastructure, healthcare, financial services, consumer businesses, specialty real estate, and telecommunications.
What stands out about Innova Capital Partners United States
Innova Capital Partners publicly describes a strategy that combines investment, development, operating support, strategic partnerships, and operational value creation across multiple sectors and company stages. The cited materials do not establish minimum investment size, ownership requirements, formal geographic mandate, or transaction terms.[1][2][3][4][6]
What does Innova Capital Partners United States invest in?
Innova Capital Partners identifies itself as a private investment firm and investment-and-operating platform. The site footer identifies the legal entity as Innova Capital Partners LLC.
The firm states that it invests, develops, and operates across venture capital, growth equity, private credit, and real assets. It also describes work with management teams and proven entrepreneurs to improve operational results.[1]
Innova describes a growth-oriented strategy based on broad opportunity sourcing, thorough due diligence, strategic partnerships, continuous improvement, business development, customer engagement, and efficient operating strategies.
Its stated platform combines capital with sector expertise and operating involvement. The public description includes investment, development, operating, and strategic partnership activities.[1][2]
Owners comparing capital alternatives can review Auxo’s capital advisory services, valuation services, and full-versus-partial sale framework.
What should a business owner evaluate before taking capital from Innova Capital Partners United States?
An owner evaluating Innova should clarify the legal entity and investment vehicle, proposed ownership structure, governance rights, financing source, investment horizon, follow-on capital capacity, monetization expectations, conflicts among portfolio companies, and regulatory status for the proposed transaction.
The cited portfolio page does not disclose transaction consideration, ownership percentages, financing terms, or governance rights. The cited homepage does not state a firm-level CRD number, SEC file number, or other regulatory registration identifier. Innova’s stated investment and operating model also makes it appropriate to clarify which operating resources and portfolio-company relationships would be available for the proposed investment.[1][4]
What legal entity and investment vehicle would make the investment
What ownership percentage, governance rights, board rights, veto rights, and reserved matters would apply
What are the proposed valuation, capitalization, financing structure, and use of proceeds
What investment criteria does Innova Capital Partners United States publicly describe?
The firm states that it invests time and capital in early-stage ventures and more mature enterprises. It also states that it partners with industry-leading management teams and companies positioned for significant growth.
The stated investment forms include venture capital, growth equity, private credit, and real assets.[1][2]
Publicly stated criteria include company stage ranging from early-stage ventures to more mature enterprises, management teams described as industry-leading, companies positioned for significant growth, and a thorough due-diligence process.
The cited strategy page does not publish a minimum or maximum investment size, fund-size target, revenue or EBITDA threshold, valuation range, or ownership requirement.[2]
The cited core-themes page describes health and wellness services provided across the country. The portfolio page also identifies Colombia-linked companies, including Erco Energia and Golden Comunicaciones.
The cited core-themes page does not publish a formal geographic mandate, geographic allocation, or country-by-country investment policy.[3]
The official portfolio page lists companies including Agile Occupational Medicine, AION Biosystems, Alsym Energy, American Bitcoin, DG Matrix, Etched, Fortify Grid, Gecko Robotics, Graviton Bioscience, Lemonaid Health, Oats Overnight, SpaceX, Spotter, and Vincent.[4]
The official portfolio page identifies Solarlytics as exited in 2025, Solar Power Solutions as exited in 2026, and xAI as bought by SpaceX in 2026.
The same page states that Lumni acquired Paytronage in May 2018 and describes Paytronage as an Innova platform company in which Innova was a seed investor.
The official news page lists 2026 developments involving portfolio companies, including Lemonaid Health’s acquisition of Dr. B’s Fitness and Longevity Business, DG Matrix’s $60 million Series A financing, and Graviton BioScience’s FDA IND clearance.[4][5]
What is not clear from Innova Capital Partners United States's public materials?
The cited strategy page does not publish a minimum or maximum investment size, fund-size target, revenue or EBITDA threshold, valuation range, or ownership requirement.
The cited core-themes page does not publish a formal geographic mandate, geographic allocation, or country-by-country investment policy.
The cited portfolio page does not disclose transaction consideration, Innova’s ownership percentage, financing terms, or governance rights for listed portfolio companies and exit annotations.
The cited homepage identifies Innova Capital Partners LLC and describes it as a private investment firm but does not state a CRD number, SEC file number, or other firm-level regulatory registration identifier. The cited clients page states that Innova works through its ventures with over 3,000 clients but does not identify the clients, explain the client-count methodology, or provide a breakdown by venture or geography.[1][2][3][4][6]
Questions to ask before taking capital from Innova Capital Partners United States
What legal entity and investment vehicle would make the investment?
What ownership percentage, governance rights, board rights, veto rights, and reserved matters would apply?
What are the proposed valuation, capitalization, financing structure, and use of proceeds?
Does Innova have a stated minimum or maximum check size or target ownership range?
What is the expected investment horizon and what circumstances would lead to a sale, recapitalization, or other monetization?
Which operating resources and portfolio-company relationships would be available for the proposed investment?
How are conflicts handled across energy, healthcare, financial-services, technology, and infrastructure holdings?
What firm-level registrations, exemptions, or regulated affiliates apply to the proposed transaction?
Sources & research notes
- Official website / firm overview
- Investment approach
- Industry / market focus
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Public disclosure information
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.
